1. Academic Validation
  2. TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells

TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells

  • Oncogene. 2015 Oct 1;34(40):5163-74. doi: 10.1038/onc.2014.437.
F Lozupone 1 M Borghi 2 F Marzoli 1 T Azzarito 1 P Matarrese 1 E Iessi 1 G Venturi 1 S Meschini 3 A Canitano 1 R Bona 1 A Cara 1 S Fais 1
Affiliations

Affiliations

  • 1 Therapeutic Research and Medicines Evaluation Department, Istituto Superiore di Sanità, Rome, Italy.
  • 2 Infectious, Parasitic and Immune-Mediated Diseases Department, Istituto Superiore di Sanità, Rome, Italy.
  • 3 Technology and Health Department, Istituto Superiore di Sanità, Rome, Italy.
Abstract

An inverted pH gradient across the cell membranes is a typical feature of malignant Cancer cells that are characterized by extracellular acidosis and cytosol alkalization. These dysregulations are able to create a unique milieu that favors tumor progression, metastasis and chemo/immune-resistance traits of solid tumors. A key event mediating tumor cell pH alterations is an aberrant activation of ion channels and proton pumps such as (H+)-vacuolar-ATPase (V-ATPase). TM9SF4 is a poorly characterized transmembrane protein that we have recently shown to be related to cannibal behavior of metastatic melanoma cells. Here, we demonstrate that TM9SF4 represents a novel V-ATPase-associated protein involved in V-ATPase activation. We have observed in HCT116 and SW480 colon Cancer cell lines that TM9SF4 interacts with the ATP6V1H subunit of the V-ATPase V1 sector. Suppression of TM9SF4 with small interfering RNAs strongly reduces assembly of V-ATPase V0/V1 sectors, thus reversing tumor pH gradient with a decrease of cytosolic pH, alkalization of intracellular vesicles and a reduction of extracellular acidity. Such effects are associated with a significant inhibition of the invasive behavior of colon Cancer cells and with an increased sensitivity to the cytotoxic effects of 5-fluorouracil. Our study shows for the first time the important role of TM9SF4 in the aberrant constitutive activation of the V-ATPase, and the development of a malignant phenotype, supporting the potential use of TM9SF4 as a target for future Anticancer therapies.

Figures